Annual Cash & Cash Equivalents
$112.77 M
-$5.80 M-4.89%
December 31, 2021
Summary
- As of February 7, 2025, AMYT annual cash & cash equivalents is $112.77 million, with the most recent change of -$5.80 million (-4.89%) on December 31, 2021.
- During the last 3 years, AMYT annual cash & cash equivalents has risen by +$102.91 million (+1043.26%).
Performance
AMYT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$83.25 M
-$7.33 M-8.10%
September 30, 2022
Summary
- As of February 7, 2025, AMYT quarterly cash and cash equivalents is $83.25 million, with the most recent change of -$7.33 million (-8.10%) on September 30, 2022.
- Over the past year, AMYT quarterly cash and cash equivalents has dropped by -$39.88 million (-32.39%).
Performance
AMYT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AMYT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.9% | -32.4% |
| 3 y3 years | +1043.3% | - |
| 5 y5 years | +370.6% | +247.4% |
AMYT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -26.2% | at low |
| 5 y | 5-year | -4.9% | -42.2% | -41.8% | -21.7% |
| alltime | all time | -4.9% | -100.0% | -41.8% | -100.0% |
Amryt Pharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $83.25 M(-8.1%) |
| Jun 2022 | - | $90.58 M(-11.3%) |
| Mar 2022 | - | $102.17 M(-9.4%) |
| Dec 2021 | $112.77 M(-4.9%) | $112.77 M(-8.4%) |
| Sep 2021 | - | $123.13 M(-13.9%) |
| Jun 2021 | - | $142.95 M(+20.6%) |
| Mar 2021 | - | $118.52 M(-0.0%) |
| Dec 2020 | $118.58 M(+81.9%) | $118.58 M(+59.0%) |
| Sep 2020 | - | $74.59 M(+11.4%) |
| Jun 2020 | - | $66.97 M(+0.0%) |
| Mar 2020 | - | $66.97 M(+2.7%) |
| Dec 2019 | $65.20 M(+561.0%) | $65.20 M(+1101.9%) |
| Jun 2019 | - | $5.42 M(-45.0%) |
| Dec 2018 | $9.86 M | $9.86 M(-30.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $14.12 M(-41.1%) |
| Dec 2017 | $23.96 M(+175.5%) | $23.96 M(+91.5%) |
| Jun 2017 | - | $12.52 M(+43.9%) |
| Dec 2016 | $8.70 M(-37.0%) | $8.70 M(-33.0%) |
| Jun 2016 | - | $12.98 M(-16.4%) |
| Dec 2015 | $13.80 M(-16.1%) | - |
| Sep 2015 | - | $15.52 M(-5.7%) |
| Mar 2015 | $16.45 M(-5.6%) | $16.45 M(-12.6%) |
| Sep 2014 | - | $18.83 M(+8.0%) |
| Mar 2014 | $17.43 M(-44.7%) | $17.43 M(+60.5%) |
| Sep 2013 | - | $10.86 M(-65.6%) |
| Mar 2013 | $31.54 M(+2949.5%) | $31.54 M(+133.2%) |
| Sep 2012 | - | $13.53 M(+1207.9%) |
| Mar 2012 | $1.03 M(>+9900.0%) | $1.03 M(>+9900.0%) |
| Mar 2011 | $1600.00 | $1600.00 |
FAQ
- What is Amryt Pharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Amryt Pharma?
- What is Amryt Pharma annual cash & cash equivalents year-on-year change?
- What is Amryt Pharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Amryt Pharma?
- What is Amryt Pharma quarterly cash and cash equivalents year-on-year change?
What is Amryt Pharma annual cash & cash equivalents?
The current annual cash & cash equivalents of AMYT is $112.77 M
What is the all time high annual cash & cash equivalents for Amryt Pharma?
Amryt Pharma all-time high annual cash & cash equivalents is $118.58 M
What is Amryt Pharma annual cash & cash equivalents year-on-year change?
Over the past year, AMYT annual cash & cash equivalents has changed by -$5.80 M (-4.89%)
What is Amryt Pharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AMYT is $83.25 M
What is the all time high quarterly cash and cash equivalents for Amryt Pharma?
Amryt Pharma all-time high quarterly cash and cash equivalents is $142.95 M
What is Amryt Pharma quarterly cash and cash equivalents year-on-year change?
Over the past year, AMYT quarterly cash and cash equivalents has changed by -$39.88 M (-32.39%)